We find parallel neuroinflammatory mechanisms, dependent on TYK2 - a potential disease-modifying target - for TDP-43-associated Alzheimer's disease and C9ORF72-ALS. Here, TARDBP is linked to early-onset autosomal dominant Alzheimer disease.